{"data":[{"accessionNo":"0001738048-26-000079","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001638097","issuerName":"Entera Bio Ltd.","ticker":"ENTX","cusip":"M40527109","securityClass":"Ordinary Shares, par value of NIS 0.0000769","eventDate":"2026-10-23","reportingPerson":"Venrock Healthcare Capital Partners III, L.P.","reportingCik":null,"personType":"PN","sharesOwned":8861763,"percentOfClass":5.1,"filedAt":"2026-10-30","canonicalUrl":"https://xoomar.com/markets/stocks/entx"},{"accessionNo":"0001738048-26-000079","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001638097","issuerName":"Entera Bio Ltd.","ticker":"ENTX","cusip":"M40527109","securityClass":"Ordinary Shares, par value of NIS 0.0000769","eventDate":"2026-10-23","reportingPerson":"VHCP Co-Investment Holdings III, LLC","reportingCik":null,"personType":"OO","sharesOwned":8861763,"percentOfClass":5.1,"filedAt":"2026-10-30","canonicalUrl":"https://xoomar.com/markets/stocks/entx"},{"accessionNo":"0001738048-26-000079","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001638097","issuerName":"Entera Bio Ltd.","ticker":"ENTX","cusip":"M40527109","securityClass":"Ordinary Shares, par value of NIS 0.0000769","eventDate":"2026-10-23","reportingPerson":"Venrock Healthcare Capital Partners EG, L.P.","reportingCik":null,"personType":"PN","sharesOwned":8861763,"percentOfClass":5.1,"filedAt":"2026-10-30","canonicalUrl":"https://xoomar.com/markets/stocks/entx"},{"accessionNo":"0001738048-26-000079","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001638097","issuerName":"Entera Bio Ltd.","ticker":"ENTX","cusip":"M40527109","securityClass":"Ordinary Shares, par value of NIS 0.0000769","eventDate":"2026-10-23","reportingPerson":"VHCP Management III, LLC","reportingCik":null,"personType":"OO","sharesOwned":8861763,"percentOfClass":5.1,"filedAt":"2026-10-30","canonicalUrl":"https://xoomar.com/markets/stocks/entx"},{"accessionNo":"0001738048-26-000079","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001638097","issuerName":"Entera Bio Ltd.","ticker":"ENTX","cusip":"M40527109","securityClass":"Ordinary Shares, par value of NIS 0.0000769","eventDate":"2026-10-23","reportingPerson":"VHCP Management EG, LLC","reportingCik":null,"personType":"OO","sharesOwned":8861763,"percentOfClass":5.1,"filedAt":"2026-10-30","canonicalUrl":"https://xoomar.com/markets/stocks/entx"},{"accessionNo":"0001738048-26-000079","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001638097","issuerName":"Entera Bio Ltd.","ticker":"ENTX","cusip":"M40527109","securityClass":"Ordinary Shares, par value of NIS 0.0000769","eventDate":"2026-10-23","reportingPerson":"Nimish Shah","reportingCik":null,"personType":"IN","sharesOwned":8861763,"percentOfClass":5.1,"filedAt":"2026-10-30","canonicalUrl":"https://xoomar.com/markets/stocks/entx"},{"accessionNo":"0001738048-26-000079","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001638097","issuerName":"Entera Bio Ltd.","ticker":"ENTX","cusip":"M40527109","securityClass":"Ordinary Shares, par value of NIS 0.0000769","eventDate":"2026-10-23","reportingPerson":"Bong Y. Koh","reportingCik":null,"personType":"IN","sharesOwned":8861763,"percentOfClass":5.1,"filedAt":"2026-10-30","canonicalUrl":"https://xoomar.com/markets/stocks/entx"},{"accessionNo":"0000921895-26-001957","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001638097","issuerName":"Entera Bio Ltd.","ticker":"ENTX","cusip":"M40527109","securityClass":"Ordinary Shares, par value NIS 0.0000769 per share","eventDate":"2026-07-28","reportingPerson":"LAMPERT MARK N","reportingCik":"0001233840","personType":"IN","sharesOwned":17225121,"percentOfClass":9.99,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/entx"},{"accessionNo":"0000921895-26-001957","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001638097","issuerName":"Entera Bio Ltd.","ticker":"ENTX","cusip":"M40527109","securityClass":"Ordinary Shares, par value NIS 0.0000769 per share","eventDate":"2026-07-28","reportingPerson":"BVF PARTNERS L P/IL","reportingCik":"0001055947","personType":"IA,PN","sharesOwned":17225121,"percentOfClass":9.99,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/entx"},{"accessionNo":"0000921895-26-001957","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001638097","issuerName":"Entera Bio Ltd.","ticker":"ENTX","cusip":"M40527109","securityClass":"Ordinary Shares, par value NIS 0.0000769 per share","eventDate":"2026-07-28","reportingPerson":"BVF INC/IL","reportingCik":"0001056807","personType":"CO","sharesOwned":17225121,"percentOfClass":9.99,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/entx"},{"accessionNo":"0000921895-26-001957","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001638097","issuerName":"Entera Bio Ltd.","ticker":"ENTX","cusip":"M40527109","securityClass":"Ordinary Shares, par value NIS 0.0000769 per share","eventDate":"2026-07-28","reportingPerson":"BVF GP HOLDINGS LLC","reportingCik":"0001803809","personType":"OO","sharesOwned":15857221,"percentOfClass":9.2,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/entx"},{"accessionNo":"0001193125-26-332895","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001638097","issuerName":"Entera Bio Ltd.","ticker":"ENTX","cusip":"M40527109","securityClass":"Ordinary Shares, par value of NIS $0.0000769","eventDate":"2026-07-28","reportingPerson":"TCG Crossover GP III, LLC","reportingCik":null,"personType":"OO","sharesOwned":12254901,"percentOfClass":7.1,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/entx"},{"accessionNo":"0001193125-26-332895","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001638097","issuerName":"Entera Bio Ltd.","ticker":"ENTX","cusip":"M40527109","securityClass":"Ordinary Shares, par value of NIS $0.0000769","eventDate":"2026-07-28","reportingPerson":"TCG Crossover Fund III, L.P.","reportingCik":null,"personType":"PN","sharesOwned":12254901,"percentOfClass":7.1,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/entx"},{"accessionNo":"0001193125-26-332895","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001638097","issuerName":"Entera Bio Ltd.","ticker":"ENTX","cusip":"M40527109","securityClass":"Ordinary Shares, par value of NIS $0.0000769","eventDate":"2026-07-28","reportingPerson":"Chen Yu","reportingCik":null,"personType":"IN","sharesOwned":12254901,"percentOfClass":7.1,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/entx"},{"accessionNo":"0001213900-26-085115","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001638097","issuerName":"Entera Bio Ltd.","ticker":"ENTX","cusip":"M40527109","securityClass":"Ordinary Shares, par value of NIS 0.0000769","eventDate":"2026-07-28","reportingPerson":"Vivo Opportunity, LLC","reportingCik":null,"personType":"OO","sharesOwned":11817401,"percentOfClass":6.9,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/entx"},{"accessionNo":"0000921895-26-001957","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001638097","issuerName":"Entera Bio Ltd.","ticker":"ENTX","cusip":"M40527109","securityClass":"Ordinary Shares, par value NIS 0.0000769 per share","eventDate":"2026-07-28","reportingPerson":"BIOTECHNOLOGY VALUE FUND L P","reportingCik":"0000918923","personType":"PN","sharesOwned":9171741,"percentOfClass":5.3,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/entx"},{"accessionNo":"0000921895-26-001957","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001638097","issuerName":"Entera Bio Ltd.","ticker":"ENTX","cusip":"M40527109","securityClass":"Ordinary Shares, par value NIS 0.0000769 per share","eventDate":"2026-07-28","reportingPerson":"BVF I GP LLC","reportingCik":"0001803805","personType":"OO","sharesOwned":9171741,"percentOfClass":5.3,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/entx"},{"accessionNo":"0001193125-26-333432","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001638097","issuerName":"Entera Bio Ltd.","ticker":"ENTX","cusip":"M40527109","securityClass":"Ordinary Shares, par value per share NIS 0.0000769","eventDate":"2026-07-28","reportingPerson":"Patrick G. Enright","reportingCik":null,"personType":"IN","sharesOwned":7843138,"percentOfClass":4.6,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/entx"},{"accessionNo":"0001193125-26-333432","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001638097","issuerName":"Entera Bio Ltd.","ticker":"ENTX","cusip":"M40527109","securityClass":"Ordinary Shares, par value per share NIS 0.0000769","eventDate":"2026-07-28","reportingPerson":"Longitude Capital Partners V, LLC","reportingCik":null,"personType":"OO","sharesOwned":7843138,"percentOfClass":4.6,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/entx"},{"accessionNo":"0001193125-26-333432","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001638097","issuerName":"Entera Bio Ltd.","ticker":"ENTX","cusip":"M40527109","securityClass":"Ordinary Shares, par value per share NIS 0.0000769","eventDate":"2026-07-28","reportingPerson":"Longitude Venture Partners V, L.P.","reportingCik":null,"personType":"PN","sharesOwned":7843138,"percentOfClass":4.6,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/entx"},{"accessionNo":"0001193125-26-333432","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001638097","issuerName":"Entera Bio Ltd.","ticker":"ENTX","cusip":"M40527109","securityClass":"Ordinary Shares, par value per share NIS 0.0000769","eventDate":"2026-07-28","reportingPerson":"Juliet Tammenoms Bakker","reportingCik":null,"personType":"IN","sharesOwned":7843138,"percentOfClass":4.6,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/entx"},{"accessionNo":"0001013594-26-000802","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001638097","issuerName":"Entera Bio, Ltd. (the \"Issuer\")","ticker":"ENTX","cusip":"M40527109","securityClass":"Ordinary Shares, par value NIS 0.0000769 per share","eventDate":"2026-07-28","reportingPerson":"Brian Liu","reportingCik":null,"personType":"IN","sharesOwned":7053898,"percentOfClass":4.1,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/entx"},{"accessionNo":"0001013594-26-000802","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001638097","issuerName":"Entera Bio, Ltd. (the \"Issuer\")","ticker":"ENTX","cusip":"M40527109","securityClass":"Ordinary Shares, par value NIS 0.0000769 per share","eventDate":"2026-07-28","reportingPerson":"Seven Fleet Capital Management LP","reportingCik":null,"personType":"OO","sharesOwned":7053898,"percentOfClass":4.1,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/entx"},{"accessionNo":"0001013594-26-000802","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001638097","issuerName":"Entera Bio, Ltd. (the \"Issuer\")","ticker":"ENTX","cusip":"M40527109","securityClass":"Ordinary Shares, par value NIS 0.0000769 per share","eventDate":"2026-07-28","reportingPerson":"Seven Fleet Capital Management GP LLC","reportingCik":null,"personType":"OO","sharesOwned":7053898,"percentOfClass":4.1,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/entx"},{"accessionNo":"0000921895-26-001957","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001638097","issuerName":"Entera Bio Ltd.","ticker":"ENTX","cusip":"M40527109","securityClass":"Ordinary Shares, par value NIS 0.0000769 per share","eventDate":"2026-07-28","reportingPerson":"BIOTECHNOLOGY VALUE FUND II LP","reportingCik":"0001102444","personType":"PN","sharesOwned":6685480,"percentOfClass":3.9,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/entx"},{"accessionNo":"0000921895-26-001957","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001638097","issuerName":"Entera Bio Ltd.","ticker":"ENTX","cusip":"M40527109","securityClass":"Ordinary Shares, par value NIS 0.0000769 per share","eventDate":"2026-07-28","reportingPerson":"BVF II GP LLC","reportingCik":"0001803806","personType":"OO","sharesOwned":6685480,"percentOfClass":3.9,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/entx"},{"accessionNo":"0001013594-26-000802","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001638097","issuerName":"Entera Bio, Ltd. (the \"Issuer\")","ticker":"ENTX","cusip":"M40527109","securityClass":"Ordinary Shares, par value NIS 0.0000769 per share","eventDate":"2026-07-28","reportingPerson":"Seven Fleet Master Fund LP","reportingCik":null,"personType":"PN","sharesOwned":5093114,"percentOfClass":3,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/entx"},{"accessionNo":"0001213900-26-085115","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001638097","issuerName":"Entera Bio Ltd.","ticker":"ENTX","cusip":"M40527109","securityClass":"Ordinary Shares, par value of NIS 0.0000769","eventDate":"2026-07-28","reportingPerson":"Vivo Opportunity Co-Invest (Cycle 3), L.P.","reportingCik":null,"personType":"PN","sharesOwned":4768382,"percentOfClass":2.8,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/entx"},{"accessionNo":"0001213900-26-085115","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001638097","issuerName":"Entera Bio Ltd.","ticker":"ENTX","cusip":"M40527109","securityClass":"Ordinary Shares, par value of NIS 0.0000769","eventDate":"2026-07-28","reportingPerson":"Vivo Opportunity Fund Holdings, L.P.","reportingCik":null,"personType":"PN","sharesOwned":4330882,"percentOfClass":2.5,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/entx"},{"accessionNo":"0001213900-26-085115","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001638097","issuerName":"Entera Bio Ltd.","ticker":"ENTX","cusip":"M40527109","securityClass":"Ordinary Shares, par value of NIS 0.0000769","eventDate":"2026-07-28","reportingPerson":"Vivo Opportunity Co-Invest, L.P.","reportingCik":null,"personType":"PN","sharesOwned":2718137,"percentOfClass":1.6,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/entx"},{"accessionNo":"0001013594-26-000802","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001638097","issuerName":"Entera Bio, Ltd. (the \"Issuer\")","ticker":"ENTX","cusip":"M40527109","securityClass":"Ordinary Shares, par value NIS 0.0000769 per share","eventDate":"2026-07-28","reportingPerson":"Seven Fleet Horizon Master Fund LP","reportingCik":null,"personType":"PN","sharesOwned":1960784,"percentOfClass":1.1,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/entx"},{"accessionNo":"0000921895-26-001957","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001638097","issuerName":"Entera Bio Ltd.","ticker":"ENTX","cusip":"M40527109","securityClass":"Ordinary Shares, par value NIS 0.0000769 per share","eventDate":"2026-07-28","reportingPerson":"BVF Partners OS Ltd.","reportingCik":"0001660684","personType":"CO","sharesOwned":1124329,"percentOfClass":0.7,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/entx"},{"accessionNo":"0000921895-26-001957","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001638097","issuerName":"Entera Bio Ltd.","ticker":"ENTX","cusip":"M40527109","securityClass":"Ordinary Shares, par value NIS 0.0000769 per share","eventDate":"2026-07-28","reportingPerson":"Biotechnology Value Trading Fund OS LP","reportingCik":"0001660683","personType":"PN","sharesOwned":1124329,"percentOfClass":0.7,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/entx"},{"accessionNo":"0001213900-26-085115","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001638097","issuerName":"Entera Bio Ltd.","ticker":"ENTX","cusip":"M40527109","securityClass":"Ordinary Shares, par value of NIS 0.0000769","eventDate":"2026-07-28","reportingPerson":"Vivo Opportunity Cayman Fund, L.P.","reportingCik":null,"personType":"PN","sharesOwned":437500,"percentOfClass":0.3,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/entx"},{"accessionNo":"0001213900-26-085115","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001638097","issuerName":"Entera Bio Ltd.","ticker":"ENTX","cusip":"M40527109","securityClass":"Ordinary Shares, par value of NIS 0.0000769","eventDate":"2026-07-28","reportingPerson":"Vivo Opportunity Cayman, LLC","reportingCik":null,"personType":"OO","sharesOwned":437500,"percentOfClass":0.3,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/entx"},{"accessionNo":"0000902664-25-005001","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001638097","issuerName":"Entera Bio Ltd.","ticker":"ENTX","cusip":null,"securityClass":"Ordinary shares, par value NIS 0.0000769 per share","eventDate":"2025-09-30","reportingPerson":"Point72 Asset Management, L.P.","reportingCik":null,"personType":"PN","sharesOwned":1183116,"percentOfClass":2.6,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/entx"},{"accessionNo":"0000902664-25-005001","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001638097","issuerName":"Entera Bio Ltd.","ticker":"ENTX","cusip":null,"securityClass":"Ordinary shares, par value NIS 0.0000769 per share","eventDate":"2025-09-30","reportingPerson":"Point72 Capital Advisors, Inc.","reportingCik":null,"personType":"CO","sharesOwned":1183116,"percentOfClass":2.6,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/entx"},{"accessionNo":"0000902664-25-005001","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001638097","issuerName":"Entera Bio Ltd.","ticker":"ENTX","cusip":null,"securityClass":"Ordinary shares, par value NIS 0.0000769 per share","eventDate":"2025-09-30","reportingPerson":"Steven A. Cohen","reportingCik":null,"personType":"IN","sharesOwned":1183116,"percentOfClass":2.6,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/entx"}],"updatedAt":"2026-11-03T22:37:44.965Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/entx","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}